273 related articles for article (PubMed ID: 12692985)
1. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
3. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
5. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
Kohno N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
[TBL] [Abstract][Full Text] [Related]
8. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
[TBL] [Abstract][Full Text] [Related]
10. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.
Al-Salmi QA; Walter JN; Colasurdo GN; Sockrider MM; Smith EO; Takahashi H; Fan LL
Chest; 2005 Jan; 127(1):403-7. PubMed ID: 15654008
[TBL] [Abstract][Full Text] [Related]
11. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F
J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311
[TBL] [Abstract][Full Text] [Related]
12. KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases.
Fukaya S; Oshima H; Kato K; Komatsu Y; Matsumura H; Ishii K; Miyama H; Nagai T; Tanaka I; Mizutani A; Katayama M; Yoshida S; Torikai K
Rheumatol Int; 2000; 19(6):223-5. PubMed ID: 11063292
[TBL] [Abstract][Full Text] [Related]
13. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
Kobayashi I; Ono S; Kawamura N; Okano M; Miyazawa K; Shibuya H; Kobayashi K
J Pediatr; 2001 Feb; 138(2):274-6. PubMed ID: 11174630
[TBL] [Abstract][Full Text] [Related]
14. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
[TBL] [Abstract][Full Text] [Related]
16. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
Kohno N
J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
[TBL] [Abstract][Full Text] [Related]
17. [Interstitial pneumonitis and serum markers (SP-D & KL-6) in collagen vascular diseases].
Sagawa A
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):55-63. PubMed ID: 15164926
[No Abstract] [Full Text] [Related]
18. [Lung injury and serum markers].
Suwabe A
Rinsho Byori; 2002 Nov; 50(11):1061-6. PubMed ID: 12491603
[TBL] [Abstract][Full Text] [Related]
19. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
[TBL] [Abstract][Full Text] [Related]
20. [Immunity tests for respiratory diseases--SP-A, SP-D, KL-6].
Kambe M; Ohshimo S; Kohno N
Rinsho Byori; 2007 Apr; 55(4):381-7. PubMed ID: 17511270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
